What Is Epidemiology? Research Areas, Funding, and Career Paths

Epidemiology is the study of how disease and other health-related events are distributed across populations, and what causes that distribution — the discipline that turns individual cases into population-level patterns, and population-level patterns into evidence for prevention and policy. Where clinical medicine asks “what is wrong with this patient and how do we treat it,” epidemiology asks “who is affected, where, when, and why, and what would change that pattern.” It is the foundational science of public health: nearly every major public-health intervention of the last century — from linking smoking to lung cancer, to identifying the source of a foodborne outbreak, to establishing that folic acid fortification reduces neural tube defects — traces back to epidemiologic study.

What Is Epidemiology, Exactly?

The most widely used definition, from epidemiologist John M. Last’s Dictionary of Epidemiology, describes it as “the study of the distribution and determinants of health-related states or events in specified populations, and the application of this study to the control of health problems.” Three ideas do the real work in that sentence:

• Distribution — how a disease or outcome is patterned by person (age, sex, occupation, genetics), place (country, region, neighborhood), and time (season, year, before/after an intervention). This descriptive layer is often the first step: establishing what the pattern actually is before asking why.
• Determinants — the exposures, behaviors, environmental factors, and biological mechanisms that explain the pattern. This is the analytic layer: testing whether an exposure is actually associated with an outcome, and how strongly, after accounting for other explanations (confounding, bias, chance).
• Application — epidemiology is explicitly not a purely observational science. Findings are meant to inform prevention, screening policy, treatment guidelines, and public-health response. An epidemiologic finding that never reaches a decision-maker has done half its job.

Epidemiologists work with a population, not an individual patient, as the unit of interest. A clinician treating a single patient with a rare cancer wants to know what will help this person; an epidemiologist wants to know why the incidence of that cancer is rising in a specific region, which exposures explain the difference, and what population-level intervention would change the trend. The two perspectives are complementary, not competing — clinical observation frequently generates the hypothesis an epidemiologic study then tests at scale.

Core questions epidemiology asks: How common is this condition, and is that changing? Who is at elevated risk, and why? Is a suspected exposure actually causing the outcome, or merely associated with it? Would removing or modifying the exposure change the outcome? Is an intervention (a vaccine, a screening program, a policy change) working, and for whom?

How Epidemiology Relates to Neighboring Disciplines

Epidemiology sits at the intersection of several fields and borrows methods from all of them, which is part of why it is easy to conflate with its neighbors:

• Biostatistics supplies the quantitative machinery — study design, sample-size and power calculations, regression modeling, survival analysis — that epidemiology applies to health data specifically. Biostatistics is the general mathematical toolkit; epidemiology is the applied discipline that uses it to answer population-health questions. See CASRAI’s companion guide on what biostatistics is for how the two fields divide labor in practice.
• Public health is the broader field concerned with protecting and improving population health through any means — policy, health education, environmental engineering, health-care access. Epidemiology is public health’s core investigative discipline: the one that tells the rest of the field where to focus and whether an intervention worked.
• Clinical medicine focuses on diagnosing and treating individual patients. Clinical epidemiology (a subfield discussed below) applies epidemiologic methods to questions that arise in clinical practice, such as how accurate a diagnostic test is or how a treatment performs across real-world patients rather than a controlled trial population.
• Microbiology and immunology explain the biological mechanism — how a pathogen replicates, how the immune system responds — while infectious disease epidemiology explains how that pathogen actually spreads through a population and what breaks the chain of transmission. CASRAI’s guide on what immunology is and its guide on what virology is cover the underlying biology that outbreak epidemiology draws on.
• Demography studies population structure and change (birth rates, migration, age distribution) as an end in itself; epidemiology borrows demographic data as a denominator — the population “at risk” against which disease counts are measured.

Major Subfields of Epidemiology

Epidemiology is not one uniform practice; it splits into subfields organized around the type of exposure, outcome, or population involved. The major ones:

• Infectious disease epidemiology — the transmission, spread, and control of pathogens, including outbreak investigation, surveillance of notifiable diseases, and modeling of transmission dynamics (basic reproduction number, herd immunity thresholds). CASRAI’s guide on outbreak investigation steps walks through the field-response sequence this subfield uses in practice.
• Chronic disease epidemiology — the distribution and determinants of non-communicable conditions such as cardiovascular disease, cancer, and diabetes, typically studied over much longer time horizons than infectious outbreaks.
• Environmental epidemiology — health effects of exposures in the physical environment: air and water pollutants, occupational hazards, chemical contaminants, radiation.
• Genetic and molecular epidemiology — how genetic variation and molecular-level biomarkers relate to disease risk at the population level, often combining epidemiologic study design with laboratory or genomic data.
• Pharmacoepidemiology — the effects (both intended and adverse) of drugs once used in real-world populations, complementing the controlled conditions of a pre-approval clinical trial. Signal detection in adverse-event databases is a core method here; see CASRAI’s dictionary entry on the FDA Adverse Event Reporting System (FAERS).
• Clinical epidemiology — applying epidemiologic methods to clinical questions: diagnostic test accuracy, prognosis, treatment effectiveness in real-world (as opposed to trial) populations.
• Social epidemiology — how social structures, socioeconomic position, and social relationships shape the distribution of health and disease.
• Occupational epidemiology — health outcomes associated with workplace exposures and conditions.
• Perinatal and reproductive epidemiology — outcomes across pregnancy, birth, and early infancy.
• Nutritional epidemiology — diet and nutrient intake as exposures in relation to disease risk.

Most working epidemiologists specialize in one or two of these while sharing the same core methodological toolkit described below.

Who Funds Epidemiology Research

Epidemiology research in the United States is funded predominantly through federal public-health and biomedical research agencies, supplemented by a smaller number of major private foundations:

• The National Institutes of Health (NIH) is the largest single funder of epidemiologic research in the US, but not through one central program — funding is distributed across several disease- and population-focused institutes, each supporting epidemiology relevant to its mission. The National Cancer Institute (NCI) funds cancer epidemiology; the National Institute of Allergy and Infectious Diseases (NIAID) funds infectious disease epidemiology; the National Heart, Lung, and Blood Institute (NHLBI) funds cardiovascular and pulmonary epidemiology; the National Institute of Environmental Health Sciences (NIEHS) funds environmental epidemiology; and the National Institute of Child Health and Human Development (NICHD) funds perinatal and reproductive epidemiology, among others. An epidemiology project’s natural NIH home follows its subject matter, not a single “epidemiology institute.”
• The Centers for Disease Control and Prevention (CDC) funds and directly conducts epidemiologic work with a more applied, public-health-response orientation than NIH’s investigator-initiated research model — including surveillance system operation, outbreak response capacity, and cooperative agreements that fund epidemiologists working inside state and local health departments.
• The National Science Foundation (NSF) funds epidemiology-adjacent work at the interface of biology, mathematics, and public health — particularly disease-modeling, biostatistical methods development, and the ecology and evolution of infectious disease — through its Directorate for Biological Sciences, though NSF’s overall footprint in human-disease epidemiology is smaller than NIH’s or CDC’s.
• Major private foundations active in the field include the Robert Wood Johnson Foundation (the largest US foundation focused specifically on health and health equity), the Bill & Melinda Gates Foundation (a major funder of global-health and infectious-disease epidemiology, particularly in low- and middle-income countries), and the Wellcome Trust (a UK-based foundation that is one of the world’s largest funders of global-health and infectious-disease research).

For researchers navigating this landscape, the practical difference that matters most is between NIH’s investigator-initiated, hypothesis-driven grant model and CDC’s more applied, capacity- and surveillance-oriented cooperative agreements — the two are not interchangeable funding relationships, and a project’s fit with one or the other shapes both the proposal and the expected deliverables.

Research Methods, Study Designs, and Tools

Epidemiology’s methodological core is study design: choosing the structure that can actually answer a given causal or descriptive question given real-world constraints (you generally cannot randomize people to smoke, or to live near a pollution source). The major designs:

• Cohort studies follow a group defined by exposure status forward in time to see who develops the outcome — strong for establishing temporal sequence, but often slow and expensive, especially for rare outcomes.
• Case-control studies start from people who already have the outcome and work backward to compare their prior exposures against a control group — efficient for rare outcomes, but more vulnerable to certain biases. See CASRAI’s comparison of case-control study vs. cohort study for how the two trade off directly.
• Cross-sectional studies measure exposure and outcome at a single point in time, useful for estimating prevalence but unable to establish which came first. See the CASRAI dictionary entry on the cross-sectional study.
• Randomized controlled trials (RCTs), while more associated with clinical medicine, are also an epidemiologic tool when the question is whether an intervention (a vaccine, a screening program, a behavioral program) changes population-level outcomes.
• Ecological and surveillance-based studies use population-level (rather than individual-level) data, including the routine disease-surveillance systems that health departments run continuously to detect unusual patterns and trigger outbreak investigations.

Whichever design is used, epidemiologists spend a large share of their effort on ruling out alternative explanations for an observed association — confounding, selection bias, information bias, and reverse causation — before attributing it to the exposure under study. Reporting the resulting work transparently is itself a methodological convention: the STROBE guidelines specify what an observational study report needs to disclose so other researchers can evaluate its design and limitations.

Common tools and technical skills include statistical software (R, SAS, Stata, and increasingly Python), geographic information systems (GIS) for spatial analysis of disease clusters, standard measures such as incidence rate ratios, odds ratios and risk ratios, and attributable risk/fraction, and — for infectious disease work specifically — genomic sequencing used to trace pathogen transmission chains. Systematic review and meta-analysis of accumulated epidemiologic evidence is a related, closely connected skill, though CASRAI treats evidence synthesis as its own topic area rather than a subfield of epidemiology proper.

Career and Training Pathways

Most practicing epidemiologists hold at least a Master of Public Health (MPH) with an epidemiology concentration; research-focused, academic, and senior public-health leadership roles typically require a PhD in epidemiology or a Doctor of Public Health (DrPH). A typical MPH curriculum covers the core study designs above, biostatistics, and public-health foundations (health policy, environmental health, social/behavioral science), often followed by an applied practicum with a health department, hospital system, or research group. A PhD adds original dissertation research and deeper methodological training, and is the standard credential for a tenure-track academic or principal-investigator role.

Career paths branch from there: state and local health departments (surveillance, outbreak response), the CDC and other federal agencies, academic research, pharmaceutical and biotech companies (pharmacoepidemiology, drug safety), hospital systems (infection control, clinical epidemiology), and international/global-health organizations. The Epidemic Intelligence Service (EIS), CDC’s applied epidemiology training and service fellowship, is a well-known entry pathway into field epidemiology specifically.

Relevant professional societies include the Society for Epidemiologic Research (SER), the American College of Epidemiology (ACE), the International Epidemiological Association (IEA) (which publishes the International Journal of Epidemiology), the Council of State and Territorial Epidemiologists (CSTE) (which maintains standardized case definitions used in US disease surveillance), and the Epidemiology Section of the American Public Health Association (APHA). Some epidemiologists also pursue the Certified in Public Health (CPH) credential administered by the National Board of Public Health Examiners.

Frequently Asked Questions

What does an epidemiologist actually do day to day?

It varies widely by role: a health-department epidemiologist may spend a day investigating a cluster of foodborne illness reports and coordinating with lab and clinical staff; an academic epidemiologist may spend it analyzing cohort data, writing a grant proposal, or reviewing manuscripts; a pharmacoepidemiologist may be mining an adverse-event database for a drug-safety signal. The shared thread is population-level analysis aimed at explaining or changing a health pattern, rather than treating individual patients.

Is epidemiology the same as public health?

No — epidemiology is one discipline within the broader field of public health. Public health also includes health policy, health education, environmental health, and health-care administration; epidemiology specifically supplies the investigative, “what is happening and why” evidence base that those other functions act on.

What is the difference between an epidemiologist and a biostatistician?

Biostatistics is the general quantitative discipline (study design theory, statistical modeling) that epidemiology applies specifically to population-health questions. In practice the two roles overlap heavily and often work side by side on the same study, with the epidemiologist typically leading the substantive research question and study design, and the biostatistician leading the formal statistical analysis.

Do you need a medical degree to become an epidemiologist?

No. Most epidemiologists hold a public-health degree (MPH, PhD, or DrPH) rather than an MD, though some physicians do pursue epidemiology training (often an MPH alongside their MD) to combine clinical and population-level perspectives, particularly in clinical epidemiology.

Related CASRAI Resources

This guide is part of CASRAI’s series on major scientific disciplines; see the overview guide to the branches of science for how epidemiology fits alongside other fields, including biostatistics, immunology, and virology. For the underlying study-design and measurement concepts referenced above, see CASRAI’s guides on outbreak investigation, the case-control vs. cohort study comparison, and the STROBE reporting guideline.